Jill Marie Broadfoot
CIK 1305178 · Chief Financial Officer · last filed 2026-02-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$572.5K
Companies
7
Total Filings
41
Lifetime Open-Market Net
$85.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ATYR | Chief Financial Officer | 38,854 | $0.44 | $17.1K | -$1.5K | 1 | 2026-02-04 |
| LIFE | Chief Financial Officer | 35,104 | $15.61 | $548.0K | $86.0K | 21 | 2026-01-09 |
| CUE | Director | — | $24.53 | — | $0 | 2 | 2026-01-06 |
| TLPH | Director | 8,547 | $0.87 | $7.5K | $0 | 2 | 2025-10-24 |
| TALPHERA, INC. (ACRX) Delisted | Director | 2,106 | $0.86 | $1.8K | $0 | 3 | 2023-12-13 |
| OTONOMY, INC. (OTIC) Delisted | Director | — | $0.08 | — | $0 | 2 | 2022-06-23 |
| Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Sr Vice President, CFO, Sec | 145,649 | — | — | $961 | 10 | 2013-04-03 |
Recent Filings · Page 4 of 5
41 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-08-01 | LIFE | Grant (A) | — | $0 | EDGAR |
| 2013-04-03 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Tax (F) | −38,121 | -$147.9K | EDGAR |
| 2013-01-15 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Mixed | +24,690 | -$7.6K | EDGAR |
| 2012-01-18 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Mixed | +27,000 | $270 | EDGAR |
| 2011-01-11 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Mixed | +60,000 | $600 | EDGAR |
| 2010-01-26 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Buy (P) | +50,000 | $500 | EDGAR |
| 2010-01-12 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Mixed | −50,000 | -$500 | EDGAR |
| 2009-01-12 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Mixed | −35,000 | -$350 | EDGAR |
| 2008-01-07 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Mixed | +7,000 | $70 | EDGAR |
| 2007-01-31 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Tax (F) | −599 | -$3.7K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.